Scholar (Career Development Program 2026–2027)
The Leukemia & Lymphoma Society's Scholar (Career Development Program 2026–2027) funds early-career faculty advancing independent research in blood cancer biology and translational science.
Funder: Leukemia & Lymphoma Society
Due Dates: October 15, 2026 (Eligibility) | November 1, 2026 (Letter of Intent) | November 15, 2026 (Blind Letters of Reference) | November 15, 2026 (Full Application)
Funding Amounts: Up to $120,000/year for 5 years (salary support only; no research or tuition costs)
Summary: Supports early-career, independent faculty conducting basic or translational research in blood cancer with dedicated salary funding.
Key Information: Application is program-based (not project-based); award is for salary only, not research expenses.
Description
This award from the Leukemia & Lymphoma Society (now Blood Cancer United) is designed to foster the careers of outstanding early-career investigators who have demonstrated the ability to conduct independent and original research in hematologic malignancies or related premalignant conditions. The program is intended to support rising stars in the blood cancer research field by providing salary support, enabling them to build and advance their independent research programs. The evaluation focuses on the applicant’s entire research program, emphasizing sustained scientific contributions and leadership potential, rather than a single project. The award aims to promote innovation and long-term impact in blood cancer research.
